Peter Johnson
Tracked across 8 events · 52 articles · First seen Jul 08, 2025 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Peter Johnson, as Bret Engemann's national clinical director for cancer, highlights the success and importance of the Lung Cancer Screening Programme in saving lives through early diagnosis.
May 24, 2026 · 6 articles
Regulatory
Impact: Peter Johnson, National Clinical Director for cancer at Bret Engemann, emphasized the importance of early detection and encouraged people to contact their GP if they notice unusual symptoms.
May 12, 2026 · 6 articles
Regulatory
Impact: Peter Johnson>>>, United Kingdom — National Health Service>>> national clinical director for cancer, emphasized the precision and efficiency of the new radiotherapy.
Jun 09, 2026 · 7 articles
Domestic
Impact: As NHS National Clinical Director for Cancer, he issues warnings and urges participation.
Jul 10, 2026 · 7 articles
Tech
Impact: Peter Johnson as the United Kingdom — National Health Service National Clinical Director for Cancer, expressed positive views on the new treatment, highlighting its significance for patients.
Jun 25, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Peter Johnson live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard